Compile Data Set for Download or QSAR
maximum 50k data
Found 120 Enz. Inhib. hit(s) with all data for entry = 7312
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189204(US9169270, 76)
Affinity DataIC50:  0.200nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189201(US9169270, 73)
Affinity DataIC50:  0.300nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189192(US9169270, 64)
Affinity DataIC50:  0.300nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189187(US9169270, 59)
Affinity DataIC50:  0.400nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189195(US9169270, 67)
Affinity DataIC50:  0.400nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189196(US9169270, 68)
Affinity DataIC50:  0.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189199(US9169270, 71)
Affinity DataIC50:  0.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189203(US9169270, 75)
Affinity DataIC50:  0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189194(US9169270, 66)
Affinity DataIC50:  0.700nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189191(US9169270, 63)
Affinity DataIC50:  0.900nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189186(US9169270, 58)
Affinity DataIC50:  1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189200(US9169270, 72)
Affinity DataIC50:  1.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189189(US9169270, 61)
Affinity DataIC50:  1.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189209(US9169270, 81)
Affinity DataIC50:  1.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189221(US9169270, 93)
Affinity DataIC50:  1.30nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189193(US9169270, 65)
Affinity DataIC50:  1.30nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189202(US9169270, 74)
Affinity DataIC50:  1.40nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189138(US9169270, 10)
Affinity DataIC50:  1.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189218(US9169270, 90)
Affinity DataIC50:  1.60nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189214(US9169270, 86)
Affinity DataIC50:  1.70nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189208(US9169270, 80)
Affinity DataIC50:  1.90nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189188(US9169270, 60)
Affinity DataIC50:  2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189217(US9169270, 89)
Affinity DataIC50:  2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189145(US9169270, 17)
Affinity DataIC50:  2.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189220(US9169270, 92)
Affinity DataIC50:  2.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189205(US9169270, 77)
Affinity DataIC50:  2.30nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189231(US9169270, 103)
Affinity DataIC50:  2.30nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189249(US9169270, 5)
Affinity DataIC50:  2.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189211(US9169270, 83)
Affinity DataIC50:  2.60nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189135(US9169270, 7)
Affinity DataIC50:  2.80nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189198(US9169270, 70)
Affinity DataIC50:  2.80nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189148(US9169270, 20)
Affinity DataIC50:  3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189207(US9169270, 79)
Affinity DataIC50:  3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189234(US9169270, 106)
Affinity DataIC50:  3.40nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189212(US9169270, 84)
Affinity DataIC50:  3.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189185(US9169270, 57)
Affinity DataIC50:  3.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189233(US9169270, 105)
Affinity DataIC50:  3.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189219(US9169270, 91)
Affinity DataIC50:  3.70nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189150(US9169270, 22)
Affinity DataIC50:  3.90nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189197(US9169270, 69)
Affinity DataIC50:  4.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189206(US9169270, 78)
Affinity DataIC50:  4.40nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189147(US9169270, 19)
Affinity DataIC50:  4.71nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189190(US9169270, 62)
Affinity DataIC50:  4.80nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189136(US9169270, 8)
Affinity DataIC50:  5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189159(US9169270, 31)
Affinity DataIC50:  5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189225(US9169270, 97)
Affinity DataIC50:  5.10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189237(US9169270, 109)
Affinity DataIC50:  5.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189235(US9169270, 107)
Affinity DataIC50:  5.70nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189229(US9169270, 101)
Affinity DataIC50:  6.10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189143(US9169270, 15)
Affinity DataIC50:  6.20nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 120 total ) | Next | Last >>
Jump to: